Abbott wins EU approval for diabetes management device

09/18/2013 | BioSpectrum Asia

The FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System by Abbott has secured the CE mark to be commercialized in Europe. The diabetes management device comes with blood glucose trend indicators to alert patients when their sugar levels are high or low and an insulin dose feature to enable clinicians to program an insulin therapy plan into the monitor.

View Full Article in:

BioSpectrum Asia

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ